Intratumoral Morphologic and Molecular Heterogeneity of Rhabd Renal Cell Carcinoma: Challenges for Personalized Therapy

Modern Pathology - United Kingdom
doi 10.1038/modpathol.2015.68
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Synchronous Metastatic Clear-Cell Renal Cell Carcinoma: A Distinct Morphologic, Immunohistochemical, and Molecular Phenotype

Clinical Genitourinary Cancer
OncologyUrology
2017English

Molecular Subtyping of Metastatic Renal Cell Carcinoma: Implications for Targeted Therapy

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2014English

Future Perspectives for Personalized Immunotherapy in Renal Cell Carcinoma

Expert Opinion on Biological Therapy
Drug DiscoveryClinical BiochemistryPharmacology
2017English

Renal Toxicity of Systemic Therapy for Renal Cell Carcinoma

Seminars in Nephrology
Nephrology
2020English

Targeted Therapy for Renal Cell Carcinoma

2011English

Personalized Therapy in Renal Cell Carcinoma: Are the Different Tyrosine Kinase Inhibitors the Same for Any Patient?

Expert Review of Precision Medicine and Drug Development
Molecular MedicineDrug DiscoveryGeneticsPharmacology
2017English

Molecular Genetics of Clear-Cell Renal Cell Carcinoma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2014English

Adjuvant Therapy After Nephrectomy for Renal Cell Carcinoma

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2018English

Personalized Molecular Targeted Therapy for Hepatocellular Carcinoma in the Era of Genome Sequencing

Translational Cancer Research
Cancer ResearchOncologyRadiologyNuclear MedicineImaging
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy